Skip to main content
Shervin Assassi, MD, Rheumatology, Houston, TX

ShervinAssassiMD

Rheumatology • Houston, TX

Professor & Director, Division of Rheumatology, University of Texas Health Science Center at Houston

Join to view full profile

Dr. Assassi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Assassi's full profile

Already have an account?

  • Office

    6431 Fannin St
    Msb 5.270
    Houston, TX 77030
    Phone+1 713-500-6900
    Fax+1 713-500-0580

Education & Training

  • University of Texas Health Science Center at Houston
    University of Texas Health Science Center at HoustonFellowship, Rheumatology, 2003 - 2005
  • University of Texas Health Science Center at Houston
    University of Texas Health Science Center at HoustonResidency, Internal Medicine, 2000 - 2003
  • Albert Ludwigs University Faculty of Medicine
    Albert Ludwigs University Faculty of MedicineClass of 1999

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 2005 - 2025

Awards, Honors, & Recognition

  • Super Doctor SuperDoctors.com
  • Fellow (FACR) American College of Rheumatology

Publications & Presentations

PubMed

Journal Articles

  • The Scleroderma Patient-Centered Intervention Network Cohort: Baseline Clinical Features and Comparison with Other Large Scleroderma Cohorts  
    Daniel E Furst, Robert Spiera, Maureen D Mayes, Lorinda Chung, Suzanne Kafaja, Virginia Steen, Shervin Assassi, Monique Hinchcliff, Rheumatology

Press Mentions

  • Durable Efficacy for Drug Preventing Lung Progression in Systemic Sclerosis
    Durable Efficacy for Drug Preventing Lung Progression in Systemic SclerosisJuly 20th, 2022
  • Higher Cardiovascular Risks in Kawasaki Disease Persist 10-plus Years
    Higher Cardiovascular Risks in Kawasaki Disease Persist 10-plus YearsNovember 8th, 2020
  • Dr. Shervin Assassi: New Chair of the ACR Committee on Journal Publications
    Dr. Shervin Assassi: New Chair of the ACR Committee on Journal PublicationsApril 18th, 2019
  • Join now to see all

Professional Memberships

Dr. Shervin Assassi, Dr. Shervin Assassi, MD, Dr. S Assassi